TAS2R43
geneOn this page
Also known as T2R52
Summary
TAS2R43 (taste 2 receptor member 43, HGNC:18875) is a protein-coding gene on chromosome 12p13.2, encoding Taste receptor type 2 member 43 (P59537). Gustducin-coupled receptor immplicated in the perception of bitter compounds in the oral cavity and the gastrointestinal tract.
TAS2R43 belongs to the large TAS2R receptor family. TAS2Rs are expressed on the surface of taste receptor cells and mediate the perception of bitterness through a G protein-coupled second messenger pathway (Conte et al., 2002 [PubMed 12584440]). For further information on TAS2Rs, see MIM 604791.
Source: NCBI Gene 259289 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 5 total
- Druggable target: yes — 1 molecules with ChEMBL bioactivity
- MANE Select transcript:
NM_176884
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18875 |
| Approved symbol | TAS2R43 |
| Name | taste 2 receptor member 43 |
| Location | 12p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | T2R52 |
| Ensembl gene | ENSG00000255374 |
| Ensembl biotype | protein_coding |
| OMIM | 612668 |
| Entrez | 259289 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000531678
RefSeq mRNA: 1 — MANE Select: NM_176884
NM_176884
CCDS: CCDS53749
Canonical transcript exons
ENST00000531678 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002156831 | 11091287 | 11092313 |
Expression profiles
Bgee: expression breadth broad, 95 present calls, max score 85.78.
Top tissues by expression
112 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.78 | gold quality |
| adrenal tissue | UBERON:0018303 | 62.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 51.85 | gold quality |
| tonsil | UBERON:0002372 | 49.84 | silver quality |
| calcaneal tendon | UBERON:0003701 | 49.66 | gold quality |
| sural nerve | UBERON:0015488 | 49.64 | silver quality |
| bone marrow cell | CL:0002092 | 48.78 | gold quality |
| apex of heart | UBERON:0002098 | 45.75 | gold quality |
| cortical plate | UBERON:0005343 | 45.09 | silver quality |
| bone marrow | UBERON:0002371 | 43.81 | gold quality |
| urinary bladder | UBERON:0001255 | 42.98 | gold quality |
| ganglionic eminence | UBERON:0004023 | 42.41 | gold quality |
| cortex of kidney | UBERON:0001225 | 42.39 | gold quality |
| ectocervix | UBERON:0012249 | 41.69 | gold quality |
| liver | UBERON:0002107 | 41.12 | gold quality |
| ovary | UBERON:0000992 | 40.77 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 40.77 | gold quality |
| ventricular zone | UBERON:0003053 | 40.66 | gold quality |
| mucosa of stomach | UBERON:0001199 | 40.54 | silver quality |
| left ovary | UBERON:0002119 | 40.28 | gold quality |
| endometrium | UBERON:0001295 | 40.18 | silver quality |
| right ovary | UBERON:0002118 | 40.03 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 39.70 | gold quality |
| cerebellar cortex | UBERON:0002129 | 39.47 | silver quality |
| cerebellum | UBERON:0002037 | 39.35 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 39.28 | silver quality |
| rectum | UBERON:0001052 | 38.48 | gold quality |
| myometrium | UBERON:0001296 | 38.10 | gold quality |
| monocyte | CL:0000576 | 38.08 | gold quality |
| uterine cervix | UBERON:0000002 | 37.54 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.49 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 10)
- hTAS2R43 and hTAS2R44 function as cognate bitter taste receptors and do not contribute to the sweet taste of saccharin and acesulfame K. (PMID:15537898)
- hT2R43 gene allele makes people more sensitive to the bitterness of an artificial sweetener, saccharin; in addition, a closely related gene’s (hT2R44’s) allele also makes people more sensitive to the bitterness of saccharin. (PMID:17702579)
- Our results show that the expression rate of some of the T2R taste receptor genes was increased significantly in patients with phantogeusia. (PMID:22397221)
- Studies indicate that bitter-tasting compounds can have specific physiological effects in Bitter-tasting compounds can have specific physiological effects in type 2 taste receptors (T2Rs)-expressing cells. (PMID:22964302)
- The mutational polymorphism TAS2R43 significantly affects susceptibility to BEN points to a potentially broad role for toxin responses in personal health risks. (PMID:23050764)
- The effect of the TAS2R43 gene on coffee liking is mediated by caffeine and in particular by the H212R variant. (PMID:24647340)
- Study demonstrates that the response profiles of the cat bitter receptors Tas2r38 and Tas2r43 are distinct from those of their orthologous human receptors (PMID:26037485)
- those with at least one sensitive TAS2R38 allele (AP or PP genotype) were more likely to report rejecting liquid medications than were those without a taster allele (AA genotype (PMID:26391354)
- Bitter Sensing TAS2R50 Mediates the trans-Resveratrol-Induced Anti-inflammatory Effect on Interleukin 6 Release in HGF-1 Cells in Culture. (PMID:33461297)
- Human intestinal bitter taste receptors regulate innate immune responses and metabolic regulators in obesity. (PMID:34784295)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tas2r136 | ENSMUSG00000053217 |
| mus_musculus | Tas2r120 | ENSMUSG00000059382 |
| rattus_norvegicus | Tas2r120 | ENSRNOG00000021445 |
| rattus_norvegicus | Tas2r136 | ENSRNOG00000029561 |
Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R4 (ENSG00000127364), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R60 (ENSG00000185899), TAS2R42 (ENSG00000186136), TAS2R19 (ENSG00000212124), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R13 (ENSG00000212128), TAS2R41 (ENSG00000221855), TAS2R40 (ENSG00000221937), TAS2R46 (ENSG00000226761), TAS2R39 (ENSG00000236398), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)
Protein
Protein identifiers
Taste receptor type 2 member 43 — P59537 (reviewed: P59537)
Alternative names: Taste receptor type 2 member 52
All UniProt accessions (1): P59537
UniProt curated annotations — full annotation on UniProt →
Function. Gustducin-coupled receptor immplicated in the perception of bitter compounds in the oral cavity and the gastrointestinal tract. Signals through PLCB2 and the calcium-regulated cation channel TRPM5. Activated by the sulfonyl amide sweeteners saccharin and acesulfame K. In airway epithelial cells, binding of bitter compounds increases the intracellular calcium ion concentration and stimulates ciliary beat frequency. May act as chemosensory receptors in airway epithelial cells to detect and eliminate potential noxious agents from the airways.
Subcellular location. Membrane. Cell projection. Cilium membrane.
Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and exclusively in gustducin-positive cells. Expressed in airway epithelia.
Miscellaneous. Most taste cells may be activated by a limited number of bitter compounds; individual taste cells can discriminate among bitter stimuli.
Similarity. Belongs to the G-protein coupled receptor T2R family.
RefSeq proteins (1): NP_795365* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007960 | TAS2R | Family |
Pfam: PF05296
UniProt features (20 total): topological domain 8, transmembrane region 7, glycosylation site 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9OXA | ELECTRON MICROSCOPY | 2.9 |
| 9OXB | ELECTRON MICROSCOPY | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P59537-F1 | 86.82 | 0.48 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 161, 176
Function
Pathways and Gene Ontology
Reactome pathways
9 pathways
| ID | Pathway |
|---|---|
| R-HSA-418594 | G alpha (i) signalling events |
| R-HSA-420499 | Class C/3 (Metabotropic glutamate/pheromone receptors) |
| R-HSA-9717207 | Sensory perception of sweet, bitter, and umami (glutamate) taste |
| R-HSA-162582 | Signal Transduction |
| R-HSA-372790 | Signaling by GPCR |
| R-HSA-388396 | GPCR downstream signalling |
| R-HSA-500792 | GPCR ligand binding |
| R-HSA-9709957 | Sensory Perception |
| R-HSA-9717189 | Sensory perception of taste |
MSigDB gene sets: 28 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOCC_CELL_PROJECTION_MEMBRANE, GOCC_MOTILE_CILIUM, GOCC_PLASMA_MEMBRANE_REGION, GOCC_CILIARY_MEMBRANE, GOCC_CILIUM, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY, GOMF_TASTE_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580), G protein-coupled receptor signaling pathway (GO:0007186), signal transduction (GO:0007165), sensory perception of taste (GO:0050909)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), taste receptor activity (GO:0008527), bitter taste receptor activity (GO:0033038)
GO Cellular Component (6): plasma membrane (GO:0005886), membrane (GO:0016020), motile cilium (GO:0031514), ciliary membrane (GO:0060170), cilium (GO:0005929), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-6 pathways:
| Category | Pathways |
|---|---|
| Signaling by GPCR | 2 |
| GPCR downstream signalling | 1 |
| GPCR ligand binding | 1 |
| Sensory perception of taste | 1 |
| Signal Transduction | 1 |
| Sensory Perception | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| detection of chemical stimulus involved in sensory perception of taste | 2 |
| transmembrane signaling receptor activity | 2 |
| cellular anatomical structure | 2 |
| cilium | 2 |
| sensory perception of bitter taste | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of bitter taste | 1 |
| taste receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cell projection membrane | 1 |
| bounding membrane of organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
372 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TAS2R43 | GNAT3 | A8MTJ3 | 882 |
| TAS2R43 | PLCB2 | Q00722 | 867 |
| TAS2R43 | TAS1R3 | Q7RTX0 | 522 |
| TAS2R43 | TAS1R2 | Q8TE23 | 512 |
| TAS2R43 | TAS1R1 | Q7RTX1 | 475 |
| TAS2R43 | OR52K2 | Q8NGK3 | 448 |
| TAS2R43 | OR2T33 | Q8NG76 | 446 |
| TAS2R43 | OR52B6 | Q8NGF0 | 445 |
| TAS2R43 | A0A087WY73 | A0A087WY73 | 436 |
| TAS2R43 | PKD2L1 | Q9P0L9 | 403 |
| TAS2R43 | OR8U1 | Q8NH10 | 398 |
| TAS2R43 | SCNN1D | P51172 | 366 |
| TAS2R43 | VN1R4 | Q7Z5H5 | 365 |
| TAS2R43 | ANKRD36C | Q5JPF3 | 365 |
| TAS2R43 | NUTM2F | A1L443 | 359 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: P0DSN6, P0DTE0, P59537, P59538, P59539, P59540, P59541, P59542, P59543, P59544, Q5Y4Y8, Q5Y4Y9, Q5Y4Z5, Q5Y4Z8, Q5Y500, Q645T2, Q645T3, Q645T4, Q645T6, Q645V2, Q645V3, Q645V4, Q645V6, Q645V7, Q645Z2, Q645Z6, Q645Z7, Q645Z9, Q646A0, Q646A1, Q646B4, Q646B9, Q646C0, Q646C1, Q646C2, Q646C3, Q646E0, Q646E1, Q646E2, Q646E3
Diamond homologs: P0DSN6, P0DTE0, P59528, P59530, P59537, P59538, P59539, P59540, P59541, P59542, P59543, P59544, Q5Y4Y8, Q5Y4Y9, Q5Y4Z5, Q5Y4Z8, Q5Y500, Q645T0, Q645T2, Q645T3, Q645T4, Q645T6, Q645T7, Q645U8, Q645V1, Q645V2, Q645V3, Q645V4, Q645V6, Q645V7, Q645V8, Q645V9, Q645Z2, Q645Z5, Q645Z6, Q645Z7, Q645Z9, Q646A0, Q646A1, Q646A2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
370 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:11091492:CAT:C | acceptor_gain | 0.7300 |
| 12:11091353:C:CC | acceptor_gain | 0.7200 |
| 12:11091622:C:CT | acceptor_gain | 0.7100 |
| 12:11091605:TCTTC:T | acceptor_gain | 0.7000 |
| 12:11091615:A:C | acceptor_gain | 0.6900 |
| 12:11091619:T:TC | acceptor_gain | 0.6700 |
| 12:11091624:C:CT | acceptor_gain | 0.6700 |
| 12:11091635:T:TC | acceptor_gain | 0.6700 |
| 12:11091856:A:C | donor_gain | 0.6600 |
| 12:11091860:T:A | donor_gain | 0.6600 |
| 12:11091625:A:T | acceptor_gain | 0.6500 |
| 12:11091494:T:TC | acceptor_gain | 0.6400 |
| 12:11091834:CA:C | donor_gain | 0.6400 |
| 12:11091835:A:AC | donor_gain | 0.6400 |
| 12:11091471:T:TA | donor_gain | 0.6200 |
| 12:11091606:CTT:C | acceptor_gain | 0.6200 |
| 12:11091617:G:C | acceptor_gain | 0.6200 |
| 12:11092285:T:TA | donor_gain | 0.6100 |
| 12:11091640:A:T | acceptor_gain | 0.6000 |
| 12:11091831:CAACA:C | donor_gain | 0.6000 |
| 12:11091520:A:AC | donor_gain | 0.5900 |
| 12:11091643:A:C | acceptor_gain | 0.5900 |
| 12:11091609:C:CC | acceptor_gain | 0.5800 |
| 12:11091631:C:CT | acceptor_gain | 0.5800 |
| 12:11091784:A:C | acceptor_gain | 0.5800 |
| 12:11091864:C:CC | acceptor_gain | 0.5800 |
| 12:11091642:C:CT | acceptor_gain | 0.5700 |
| 12:11091610:T:C | acceptor_gain | 0.5600 |
| 12:11091632:A:T | acceptor_gain | 0.5500 |
| 12:11091859:CTCCT:C | acceptor_gain | 0.5500 |
AlphaMissense
2051 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:11091876:A:C | F118L | 0.850 |
| 12:11091876:A:T | F118L | 0.850 |
| 12:11091878:A:G | F118L | 0.850 |
| 12:11091921:G:C | S103R | 0.849 |
| 12:11091921:G:T | S103R | 0.849 |
| 12:11091923:T:G | S103R | 0.849 |
| 12:11092152:G:C | F26L | 0.807 |
| 12:11092152:G:T | F26L | 0.807 |
| 12:11092154:A:G | F26L | 0.807 |
| 12:11092179:A:C | F17L | 0.794 |
| 12:11092179:A:T | F17L | 0.794 |
| 12:11092181:A:G | F17L | 0.794 |
| 12:11091528:G:C | F234L | 0.782 |
| 12:11091528:G:T | F234L | 0.782 |
| 12:11091530:A:G | F234L | 0.782 |
| 12:11091945:G:C | S95R | 0.778 |
| 12:11091945:G:T | S95R | 0.778 |
| 12:11091947:T:G | S95R | 0.778 |
| 12:11091891:G:C | F113L | 0.759 |
| 12:11091891:G:T | F113L | 0.759 |
| 12:11091893:A:G | F113L | 0.759 |
| 12:11092052:A:G | W60R | 0.727 |
| 12:11092052:A:T | W60R | 0.727 |
| 12:11092197:A:C | S11R | 0.708 |
| 12:11092197:A:T | S11R | 0.708 |
| 12:11092199:T:G | S11R | 0.708 |
| 12:11091941:A:G | W97R | 0.706 |
| 12:11091941:A:T | W97R | 0.706 |
| 12:11092158:A:C | N24K | 0.702 |
| 12:11092158:A:T | N24K | 0.702 |
dbSNP variants (sampled 300 via entrez): RS1007662416 (12:11094028 T>C), RS1012269965 (12:11091208 ACAGTATAGAAAAAC>A), RS1013805753 (12:11093243 G>A), RS1027600496 (12:11093913 A>C), RS1027736262 (12:11091287 C>T), RS1036946262 (12:11093287 C>A), RS1055252053 (12:11093056 G>A,C), RS111592023 (12:11090830 G>A,C), RS111630914 (12:11092511 T>G), RS111846092 (12:11091361 A>G,T), RS111852557 (12:11090837 A>T), RS111982292 (12:11091833 A>C,G), RS112843826 (12:11092546 A>C), RS112869592 (12:11092322 G>A,C,T), RS112874084 (12:11092516 T>A,C)
Disease associations
OMIM: gene MIM:612668 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002144_2 | Bitter taste perception | 2.000000e-19 |
| GCST005688_8 | Idiopathic intracranial hypertension | 6.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523251 (SINGLE PROTEIN)
Molecules with ChEMBL bioactivity
1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 40,234 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).
| Molecule | Name | Phase | Patents |
|---|---|---|---|
| CHEMBL434 | ISOPROTERENOL | 4 | 40,234 |
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Taste 2 receptors
Most potent curated ligand interactions (13 total), top 13:
| Ligand | Action | Affinity | Parameter |
|---|---|---|---|
| aristolochic acid | Agonist | 7.1 | pEC50 |
| lactucopicrin | Agonist | 6.34 | pEC50 |
| aloin | Agonist | 5.92 | pEC50 |
| Cyclolinopeptide 1-Mso,3-Met-CL6 | Agonist | 5.53 | pEC50 |
| bengalensol | Agonist | 5.41 | pEC50 |
| grosheimin | Agonist | 5.16 | pEC50 |
| GIV3727 | Antagonist | 4.95 | pIC50 |
| 3-methylhexanal | Antagonist | 4.13 | pIC50 |
| amarogentin | Agonist | 4.12 | pEC50 |
| citronellal | Antagonist | 4.08 | pIC50 |
| saccharin | Agonist | 2.77 | pEC50 |
| acesulfame | Agonist | 2.51 | pEC50 |
| cyclamate | Antagonist | 2.32 | pIC50 |
ChEMBL bioactivities
1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.31 | EC50 | 4.9 | nM | ISOPROTERENOL |
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Folic Acid | affects cotreatment, increases expression, decreases expression | 2 |
| alloin | decreases reaction, increases activity | 1 |
| pentanal | decreases expression | 1 |
| MT19c compound | increases expression | 1 |
| Ethanol | affects cotreatment, increases expression | 1 |
| Probenecid | decreases reaction, increases activity, decreases activity | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Sodium Selenite | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
ChEMBL screening assays
10 unique, capped per target: 10 functional
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4346436 | Functional | Antagonist activity at recombinant human TAS2R43 transiently expressed in HEK293T co-expressing Galpha16gust44 assessed as inhibition of aristolochic acid-induced intracellular calcium level by measuring remaining activity at 25 uM by fluo- | Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Acesulfame, Saccharin
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): pseudotumor cerebri